NCT04928157View on ClinicalTrials.gov

Prospective Randomized Trial of CPAP for SDB in Patients Who Use Opioids

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

August 10, 2021

Primary Completion Date

September 12, 2024

Study Completion Date

September 12, 2024

Conditions
Sleep Disorder; Breathing-RelatedPainSleep ApneaObstructive Sleep ApneaSleepSleep DisorderChronic PainOpioid Use
Interventions
DEVICE

Positive Airway Pressure (PAP)

A device used with a nose or face mask which delivers airflow/pressure into the airway, holding the airway open and keeping it from collapsing. Device will be used for 8 weeks.

Trial Locations (1)

92037

University of California San Diego, San Diego

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of California, San Diego

OTHER

NCT04928157 - Prospective Randomized Trial of CPAP for SDB in Patients Who Use Opioids | Biotech Hunter | Biotech Hunter